Perbak Capital Partners »

Apellis Pharmaceuticals shares owned by Perbak Capital Partners

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Perbak Capital Partners from 13F filings

Historical chart of Perbak Capital Partners investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Perbak Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Perbak Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $257k 10k 25.12

More positions owned by Perbak Capital Partners

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr State Street Ind (XLI)
Vaneck Etf Trust Oil Services Etf (OIH)
Spdr Series Trust State Street Spd (KIE)
Select Sector Spdr Tr State Street Con (XLP)
Ishares Tr Ishares Semicdtr (SOXX)
Spdr Series Trust State Street Spd (XRT)
Waters Corporation (WAT)
RBC Bearings Incorporated (RBC)
Qiagen Nv Com Shs
Illumina (ILMN)
Spdr Series Trust State Street Spd (XHB)
Danaher Corporation (DHR)
Mettler-Toledo International (MTD)

View all positions for Perbak Capital Partners

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Wellington Management Company
Deep Track Capital
Rtw Investments
BlackRock
State Street Corporation
AQR Capital Management
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors
Geode Capital Management
Jennison Associates

View all funds holding Apellis Pharmaceuticals